ImportantUpdates

Company reported FY26 revenue of ₹4,290 Cr and PAT of ₹857 Cr (up 19%). Product innovation in Whisper & Vicks drove growth.

A shift to contract manufacturing for Vicks up to ₹1,000 Cr/year is approved.

Ms. Srividya Srinivasan is appointed Whole-time Director & CFO.

Read the original filing(PDF)

No comments yet. Be the first.

More from Procter & Gamble Hygiene and Health Care Limited

All announcements